O
Our business

Press releases

#
07 Jan 2021

Anish Mehta appointed as Chief Executive Officer and member of the Board of Directors

read more
#
16 Sept 2020

Mylan and Development Partner, Synthon, Win Significant EPO Ruling Related to Copaxone® 40mg/mL

read more
#
02 Jul 2019

BC Partners to Acquire Synthon International Holding B.V.

read more
#
05 Oct 2017

Regulatory Approval in Europe granted for Synthon’s glatiramer acetate 40 mg/ml

read more
#
13 Sept 2017

European Patent Office decides in Synthon’s favor in glatiramer patent case

read more
#
12 Apr 2016

Synthon obtains approval for glatiramer acetate 20 mg/mL in Europe

read more
#
03 Aug 2015

Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis

read more
#
28 Apr 2015

Synthon Announces Successful Outcomes from the Open-label extension of the Phase III GATE Study of Synthon’s Glatiramer Acetate

read more
#
09 Oct 2014

Synthon Announces Filing of Glatiramer Acetate 40 mg/mL ANDA Containing a Paragraph IV Certification

read more
#
15 Apr 2014

Synthon obtains European approvals for sevelamer

read more
     Share this page
Archive